✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Revolution Medicines Inc

Common Name
Revolution Medicines
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
883
Ticker
RVMD
Exchange
NASDAQ/NGS
Description
Revolution Medicines is a late-stage clinical oncology company focused on developing targeted therapies for cancers driven by the RAS protein, one of the most common cancer drivers affecting approxima...

Revolution Medicines's Board and Committee Meetings Data

Explore Revolution Medicines's board and committee governance data, including meeting counts and attendance rates for the board, audit committee, compensation/remuneration committee, and nomination committee.

Metric2025
Board Meeting Count
15a
Board Meeting Attendance Rate
75%a
Audit Committee Meeting Count
4a
Audit Committee Meeting Attendance Rate
75%a
Compensation/Remuneration Committee Meeting Count
5a
Compensation/Remuneration Committee Meeting Attendance Rate
75%a
Nomination Committee Meeting Count
3a
Nomination Committee Meeting Attendance Rate
75%a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind Revolution Medicines’s Board and Committee Meetings Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Revolution Medicines's DEF 14A 2025